News
10-10-2009, 04:03 AM
Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.
More... (http://www.medicalnewstoday.com/articles/166980.php)
More... (http://www.medicalnewstoday.com/articles/166980.php)